Joehlin-Price AS, Komforti MK, Ladwig NR, Devine P, et al. HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy. Am J Surg Pathol 2023 Mar 20. doi: 10.1097/PAS.0000000000002030.
PMID: 36939053